Availability: Άμεσα Διαθέσιμο

Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cell Therapy, 2nd Edition

ISBN: 9781119823124
Εκδόσεις:
Διαστάσεις 28 × 22 cm
Μορφή

Εκδόσεις

Ημ. Έκδοσης

Σελίδες

Έκδοση

Συγγραφείς

, , , ,

Κύριος Συγγραφέας

Original price was: 132,00€.Η τρέχουσα τιμή είναι: 124,00€.(Περιλαμβάνεται ΦΠΑ 6%)

Διαθέσιμο - Προπαραγγελία|Διαθεσιμότητα: 23-28 ημέρες

Περιγραφή

Comprehensive, condensed new edition covering the entire specialties of Hematology/Oncology and Cellular Therapy (Volumes 1 and 2)

Cancer Consult: Expertise for Medical Oncology/Hematology and Cellular Therapy, Second Edition includes hundreds of painstakingly developed multiple-choice and open-ended questions covering the principles, uncertainties, and controversies of medical oncology, neoplastic hematology, hematopoietic stem cell transplant and cellular therapies including comprehensive chapters on different aspect of cancer supportive care. This textbook also contains mini-cases and questions dealing with the biology, diagnosis, classification, staging, and multidisciplinary treatment of cancers. This book also includes:

  • Streamlined, engaging content to make finding information easier and more beneficial to the reader
  • Up-to-date information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, cellular therapy, CAR T-cell therapy and translational cancer research
  • Concise and practical expert perspectives that reference key studies and journals
  • References to the latest NCCN and other national guidelines

With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, Cancer Consult: Expertise for Medical Oncology/Hematology and Cellular Therapy, Second Edition (Volumes 1 and 2) will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM hematology and oncology fellowship and recertification exams onboards.

 

 

Syed Ali Abutalib, MD, is Co-Director of Hematology and Stem Cell Transplantation and Clinical Director of NMDP® Apheresis Center at the Midwest Branch of Cancer Treatment Centers of America, (CTCA), an affiliate of City of Hope.

Maurie Markman, MD, is Senior Vice President of Clinical Affairs and National Director of Medical Oncology at Cancer Treatment Centers of America (CTCA), an affiliate of City of Hope. Dr. Markman has served as the Vice President for Clinical Research at MDACC, Chairman of the Department of Hematology/Oncology and Director of the Taussig Cancer Center at the Cleveland Clinic Foundation and Vice Chairman of the Department of Medicine at MSKCC.

James O. Armitage, MD, is the Joe Shapiro Professor of Medicine at University of Nebraska Medical Center and has served as Dean for College of Medicine and Chairman of Internal Medicine. He is past President of both the ASCO and the ASTCT.

Kenneth Anderson, MD, is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. He is past President of ASH.

Hope S. Rugo, MD, FASCO, is Director of Breast Oncology and Clinical Trials Education and a Professor of Medicine at the University of California San Francisco Comprehensive Cancer Center.

Al B. Benson III, M.D FACP FASCO is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois, and the Associate Director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center.